Variant report
| Variant | nsv526808 |
|---|---|
| Chromosome Location | chr9:10679889-10692461 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs568898825 | chr9:10685616-10685617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs7027157 | chr9:10685618-10685619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs372243950 | chr9:10685661-10685662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs111404623 | chr9:10685669-10685670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs182894608 | chr9:10685676-10685677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs574995140 | chr9:10685686-10685687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs114827192 | chr9:10685696-10685697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs73404104 | chr9:10685697-10685698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs187574892 | chr9:10685709-10685710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs62540777 | chr9:10685715-10685716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs377057631 | chr9:10685716-10685717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs545116487 | chr9:10685720-10685721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs368390133 | chr9:10685723-10685724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs530496605 | chr9:10685751-10685752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs73404105 | chr9:10685762-10685763 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 16 | rs79928859 | chr9:10685778-10685779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs529920357 | chr9:10685826-10685827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs546429917 | chr9:10685836-10685837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs560220936 | chr9:10685838-10685839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs568541128 | chr9:10685856-10685857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs532507811 | chr9:10685942-10685943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs552247429 | chr9:10685953-10685954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs568947481 | chr9:10685957-10685958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs537816795 | chr9:10685966-10685967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs548887525 | chr9:10685983-10685984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs568615359 | chr9:10686001-10686002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs193045916 | chr9:10686003-10686004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs139142650 | chr9:10686040-10686041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs12342871 | chr9:10686041-10686042 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 30 | rs74799609 | chr9:10686042-10686043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs185802937 | chr9:10686074-10686075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs537446319 | chr9:10686096-10686097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs143990668 | chr9:10686098-10686099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs189113266 | chr9:10686102-10686103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs540418735 | chr9:10686157-10686158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs557471894 | chr9:10686188-10686189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs561237594 | chr9:10686190-10686191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs10511552 | chr9:10686202-10686203 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 39 | rs540510099 | chr9:10686233-10686234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs146503294 | chr9:10686242-10686243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs532150489 | chr9:10686260-10686261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs192806268 | chr9:10686273-10686274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs532210001 | chr9:10686289-10686290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs368876146 | chr9:10686298-10686299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs562617171 | chr9:10686319-10686320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs560515812 | chr9:10686322-10686323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs531735523 | chr9:10686381-10686382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs139978688 | chr9:10686399-10686400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs568433420 | chr9:10686400-10686401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs116489703 | chr9:10686618-10686619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Variant related diseases (count:102)
| Disease | PMID | Source |
|---|---|---|
| abnormal development | 18461090 | CNVD |
| Disorders of sex development | 21048976 | CNVD |
| Honadal dysgenesis | 21048976 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Lung cancer | 16740712 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Follicular lymphoma | 17170743 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Hodgkin''s lymphoma | 18641027 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Breast cancer | 16272173 | CNVD |
| Hepatocellular carcinoma | 16750200 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Retinoblastoma | 22278416 | CNVD |
| Splenic marginal zone lymphoma | 18492102 | CNVD |
| Melanoma | 18172304 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Gastric cancer | 21586687 | CNVD |
| Esophageal squamous carcinoma | 18350619 | CNVD |
| Myopathy | 18421352 | CNVD |
| Neuroblastoma | 18664255 | CNVD |
| Acute lymphoblastic leukemia | 18957548 | CNVD |
| Myeloproliferative neoplasm | 17564968 | CNVD |
| Malignant meningioma | 17937814 | CNVD |
| Glioma | 21971842 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Hepatocellular carcinoma | 22174799 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Cutaneous squamous cell carcinomas | 19131950 | CNVD |
| Small bowel adenocarcinoma | 21586687 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Chordoma | 18071362 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Chordoma | 21602918 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Developmental delay | 19490664 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| microdeletion syndrome | 16199537 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Cancer | 20164919 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Lung cancer | 18438408 | CNVD |
| XY gonadal dysgenesis | 20685758 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Oral cancer | 21386901 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Esophageal adenocarcinoma | 19417022 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Renal cell carcinoma | 21668985 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Autism | 22495311 | CNVD |
| Hepatocellular carcinoma | 18803288 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Glioblastoma | 19074898 | CNVD |
| Malignant melanoma | 19074898 | CNVD |
| Prostate cancer | 16573809 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Cancer | 20164920 | CNVD |
| Developmental delay | 21147756 | CNVD |
| small cell lung cancer | 21764851 | CNVD |
| Glioblastoma multiforme | 22286061 | CNVD |
| Glioma | 17123091 | CNVD |
| Lung cancer | 16773561 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| Esophageal squamous carcinoma | 18405350 | CNVD |
| Gastric cancer | 16891809 | CNVD |
| Mental retardation | 17847001 | CNVD |
| Cutaneous squamous cell carcinomas | 17420988 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Pilocytic astrocytoma | 18670637 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21611746 | CNVD |
| Melanoma | 22183965 | CNVD |
| Barrett''s syndrome | 19417022 | CNVD |
| low-grade B-cell lymphoma tumor | 18367492 | CNVD |
| Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr9:10685600-10686400 | Enhancers | Placenta Amnion | Placenta Amnion |
| 2 | chr9:10686600-10687800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
| 3 | chr9:10687200-10688000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
| 4 | chr9:10687400-10688000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
| 5 | chr9:10687400-10688000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
